A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery

Anesthesia and Analgesia

Volumn 82, Issue 4, 1996, Pages 832-836

  Nishina, Kahoru ^a   Mikawa, Katsuya ^a   Maekawa, Nobuhiro ^a   Takao, Yumiko ^a   Shiga, Makoto ^a   Obara, Hidefumi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTIVE SURGERY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; STOMACH SECRETION; SURGICAL PATIENT; ULCER HEALING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-ULCER AGENTS; GASTRIC JUICE; HISTAMINE H2 ANTAGONISTS; HUMANS; MIDDLE AGED; OMEPRAZOLE; PREOPERATIVE CARE; RANITIDINE; SECRETORY RATE;

EID: 0029947545     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199604000-00027     Document Type: Article

References (25)

1. Lunn JN, Mushin WW. Mortality associated with anaesthesia. London: Nuffield Provincial Hospitals Trust, 1982.
2. Moyers JR. Preoperative medication. In: Barash PG, Cullen BF, Stoelting RK, eds. Clinical anesthesia. Philadelphia: JB Lippincott, 1989:485-503.
3. Moore J, Flynn RJ, Sampaio M, et al. Effect of single dose omeprazole on intragastric acidity and volume during obstetric anaesthesia. Anaesthesia 1989;44:559-62.
4. Clissold SP, Campoli-Richards DM. Omeprazole, a preliminary review of its pharmacodynamic properties and therapeutic potential in peptic ulcer and Zollinger-Ellison syndrome. Drugs 1986;32:15-47.
5. Barradll LB, Faulds D, McTavish D. Lansoprazole: a review of its pharmacodynamics and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs 1992;44: 225-50.
6. Miwa K, Mitani M, Tsukamoto T, et al. Metabolic fate of AG-1749, a new proton pump inhibitor, in rats, mice, and dogs. Jpn Pharmacol Ther 1990;18:3413-35.
7. Escolano F, Castaño J, Lopez R, et al. Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery. Br J Anaesth 1992;69:404-6.
8. Ewart MC, Yau G, Gin T, et al. A comparison of the effect of omeprazole and ranitidine on gastric secretion in women undergoing elective caesarean section. Anaesthesia 1990;45:527-30.
9. Hawkey CJ, Long RG, Bardhan KD, et al. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut 1993;34: 1458-62.
10. Hert DA, Scott RC, Risdall JE. Lansoprazole in the prophylaxis of acid aspiration during elective surgery. Br J Anaesth 1995;74: 614-5.
11. Mikawa K, Nishina K, Maekawa N, et al. Lansoprazole reduces preoperative gastric fluid acidity and volume in children. Can J Anaesth 1995;42:467-72.
12. Maltby JR, Elliott RH, Warnell I, et al. Gastric fluid volume and pH in elective surgical patients: triple prophylaxis is not superior to ranitidine alone. Can J Anaesth 1990;37:650-5.
13. Escolano F, Castano J, Lopez R, et al. Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery. Br J Anaesth 1992;69:404-6.
14. Roberts RB, Shirley MA. Reducing the risk of acid aspiration during caesarean section. Anesth Analg 1974;53:859-68.
15. Orr DA, Bill KM, Gillon KRW, et al. Effects of omeprazole, with and without metoclopramide, in elective obstetric anaesthesia. Anaesthesia 1993;48:114-9.
16. Nishina K, Mikawa K, Maekawa N, et al. Omeprazole reduces preoperative gastric fluid acidity and volume in children. Can J Anaesth 1994;41:925-9.
17. Hongo M, Ohara S, Hirasawa Y, et al. Effect of lansoprazole on intragastric pH: comparison between morning and evening dosing. Dig Dis Sci 1992;37:882-90.
18. Olbe L, Lind T, Cederberg C, Ekenved G. Effect of omeprazole on gastric acid secretion in man. Scand J Gastroenterol 1986; 21(Suppl 118):105-7.
19. Kihira K, Yoshida Y, Kasano T, et al. Effect of a proton pump inhibitor AG-1749 (lansoprazole) on intragastric pH: 24-hour intragastric pH monitoring. Jpn J Gastroenterol 1991;88:672-80.
20. Inoue M, Shirakawa T, Kajiyama G, et al. Clinical study of a proton pump inhibitor, omeprazole (1). The effect on gastric acid secretion by continuous intragastric pH monitoring. Basic Pharmacol Ther 1988;16:493-503.
21. +-ATPase inhibitor, on gastric pH and serum gastrin. Aliment Pharmacol Ther 1992;6:359-72.
22. Yamagata S. 24-Hour intragastric pH monitoring. Diagn Treatment 1987;75:439-44.
23. Vidon N, Dutreuil C, Scoule JC, Delchier JC. Does lansoprazole influence postprandial digestive function? Aliment Pharmacol Ther 1993;7:629-34.
24. Taylor WJ, Champion MC, Barry AW, Hurtiig JB. Measuring gastric contents during general anaesthesia: evaluation of blind gastric aspiration. Can J Anaesth 1989;36:51-4.
25. Hardy J-F, Plourde G, Lebrun M, et al. Determining gastric contents during general anaesthesia: evaluation of two methods. Can J Anaesth 1987;34:474-7.